BEAM (Beam Therapeutics) Debt-to-Equity : 0.14 (As of Mar. 2025)

Beam Therapeutics Debt-to-Equity Chart

Beam Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Equity	Get a 7-Day Free Trial															0.18	0.19	0.21	0.22	0.14

Competitive Comparison of Beam Therapeutics's Debt-to-Equity

For the Biotechnology subindustry, Beam Therapeutics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beam Therapeutics's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beam Therapeutics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Beam Therapeutics's Debt-to-Equity falls into.

Beam Therapeutics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Beam Therapeutics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Beam Therapeutics's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beam Therapeutics  (NAS:BEAM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Beam Therapeutics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Beam Therapeutics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Beam Therapeutics Business Description